The PSTI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSTI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PSTI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PSTI Detailed Price Forecast - CNN Money||View PSTI Detailed Summary - Google Finance|
|View PSTI Detailed Summary - Yahoo! Finance||View PSTI Stock Research & Analysis - Zacks.com|
|View PSTI Trends & Analysis - Trade-Ideas||View PSTI Major Holders - Barrons|
|View PSTI Call Transcripts - NASDAQ||View PSTI Breaking News & Analysis - Seeking Alpha|
|View PSTI Annual Report - CompanySpotlight.com||View PSTI OTC Short Report - OTCShortReport.com|
|View PSTI Fundamentals - TradeKing||View PSTI SEC Filings - Bar Chart|
|View Historical Prices for PSTI - The WSJ||View Performance/Total Return for PSTI - Morningstar|
|View the Analyst Estimates for PSTI - MarketWatch||View the Earnings History for PSTI - CNBC|
|View the PSTI Earnings - StockMarketWatch||View PSTI Buy or Sell Recommendations - MacroAxis|
|View the PSTI Bullish Patterns - American Bulls||View PSTI Short Pain Metrics - ShortPainBot.com|
|View PSTI Stock Mentions - StockTwits||View PSTI Stock Mentions - PennyStockTweets|
|View PSTI Stock Mentions - Twitter||View PSTI Investment Forum News - Investor Hub|
|View PSTI Stock Mentions - Yahoo! Message Board||View PSTI Stock Mentions - Seeking Alpha|
|View Insider Transactions for PSTI - SECform4.com||View Insider Transactions for PSTI - Insider Cow|
|View PSTI Major Holdings Summary - CNBC||View Insider Disclosure for PSTI - OTC Markets|
|View Insider Transactions for PSTI - Yahoo! Finance||View Institutional Holdings for PSTI - NASDAQ|
|View PSTI Stock Insight & Charts - FinViz.com||View PSTI Investment Charts - StockCharts.com|
|View PSTI Stock Overview & Charts - BarChart||View PSTI User Generated Charts - Trading View|
Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the Company has fully enrolled the second cohort of six patients in its ongoing Phase I clinical study evaluating PLX-R18 for the treatment of incomplete hematopoietic recovery following hematopoietic cell transplantation (HCT), and has received Data and Safety Monitoring Board (DSMB) approval to continue to the final cohort of the study. “We are highly encouraged by the findings from the first two cohorts in this study, and we are pleased to receive DSMB approval to continue with the study as planned, as we look to efficiently advance PLX-R18 through clinical development,” commented Zami Aberman, Chairman and Co-Chief Executive Officer of Pluristem.
Is Pluristem Therapeutics Inc.’s (NASDAQ:PSTI) Balance Sheet A Threat To Its Future?
Posted on Thursday March 07, 2019
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Pluristem Therapeutics Inc. (NASDAQ:PSTI), as the company does not have to adhere to strict debt covenants. However, it also facesRead More...
Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions
Posted on Wednesday February 20, 2019
Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced a collaboration between the company and NASA’s Ames Research Center to evaluate the potential of Pluristem’s PLX cell therapies in preventing and treating medical conditions caused during space missions. Dr. Ruth Globus of NASA’s Ames Research Center, in California’s Silicon Valley, has been awarded a 2019 NASA Ames Research Innovation Award (ARIA) for the collaboration with Pluristem.
Pluristem Therapeutics Sees Hammer Chart Pattern: Time to Buy?
Posted on Thursday February 14, 2019
Pluristem Therapeutics Inc. (PSTI) has been struggling lately, but the selling pressure may be coming to an end soon.